Government Relations

Government Relations

Updated MLA Outreach Toolkit 

Budget 2018-19 was tabled by the Government of Manitoba on March 12, 2018 and unfortunately did not address the financial impacts of the new generic drug pricing framework. However, this does not mean the end of our campaign for a reinvestment strategy. The opportunity still remains to work with government to help address the $95,000 average impact that this new pricing framework will have on pharmacies.

We at Pharmacists Manitoba’s headquarters continue to engage in a dialogue with the Minister of Health’s Office, but in order to influence government more broadly we need all of our association members from across the province to participate in our letter writing campaign.

To those who have already written to their MLA – thank you. We have attached a follow up letter to this email, with positive survey results of Manitobans, that demonstrate substantial public support for the initiatives we are proposing.

To those who have yet to write to their MLA – there is no better time than now.

Letter Option 1 (click here)

Letter Option 2 (click here)

Pan Canadian Drug Price Reduction Update

Pharmacists Manitoba has requested Manitoba Health consider a washout period to allow our pharmacists to reduce inventory and avoid significant losses. It appears our request will not be considered.

Information on Pan Canadian drug price reductions can be accessed at:

This information is not specific to Manitoba and Manitoba Health has not yet released formulary information, however we have been advised the price reductions will occur April 1, 2018.

We would encourage pharmacies to use this information to adjust their inventory accordingly.

We will keep our members updated with any information provided to us from Manitoba Health.

Pan-Canadian Pharmaceutical Alliance - MLA Outreach Toolkit

In response to the pan-Canadian Pharmaceutical Alliance (pCPA) and governments across Canada announcing a new generic drug price framework that will reduce the price of generic drugs, we have embarked on a government relations campaign to:

  • Ensure the implementation of the pan-Canadian Pharmaceutical Alliance decision is made based on consultations with pharmacists, and provides pharmacies time to adapt to any changes.
  • Present a gain-sharing strategy to the Government of Manitoba that will provide specific initiatives to provide positive health outcomes for Manitobans.
    • Through consultations with our Economic Advisory Council, we have decided to advocate for funding for post-discharge medication reconciliations, comprehensive medication reviews, and enhanced assessment and prescribing abilities.

Over the last few weeks, we’ve provided you with information on what we plan to do about these upcoming changes and on what these changes mean to you as Pharmacists.

This week, we learned that these changes will result in an average cost per Manitoba pharmacy of $95,000.

As further economic analysis comes in, we will continue to share with our members and provide relevant updates to our outreach toolkits.

To best influence the Government of Manitoba, we need our membership to contact their MLAs.

The Government of Manitoba has announced March 12th as their budget date, so we need our members to act quickly to make a difference.

Included with this email is an MLA Outreach Toolkit and Letters to help ensure our members have the needed tools at their disposal to play a significant role in this campaign:

  • Letters to MLA
  • Patient Testimonials
  • Patient Testimonials
  • Fact Sheet
  • Key Messages
  • Pharmacy Tour Guide
  • Your efforts will be critical to the success of this campaign.

    Thank you in advance for the constructive role you will play in ensuring that the Government of Manitoba sees that the new pan-Canadian Pharmaceutical Alliance agreement is an opportunity to increase the accessibility and quality of healthcare services for our patients.